세계의 의약품 콜드체인 포장 시장 규모, 점유율, 동향 분석 : 재료별, 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Pharmaceutical Cold Chain Packaging Market Summary

The global pharmaceutical cold chain packaging market size was estimated at USD 17.93 billion in 2024 and is projected to reach USD 63.30 billion by 2033, growing at a CAGR of 15.3% from 2025 to 2033. The market is driven by the rising demand for temperature-sensitive biologics, vaccines, and specialty drugs that require strict thermal protection during storage and transportation.

Additionally, stringent regulatory guidelines for maintaining product integrity and safety are fueling investments in advanced cold chain packaging solutions. Biologics, including monoclonal antibodies and cell & gene therapies, are highly sensitive to temperature fluctuations and must be stored between 2°C to 8°C or even at ultra-low temperatures of -80°C. For instance, during the COVID-19 pandemic, vaccines from Pfizer-BioNTech and Moderna highlighted the critical role of advanced cold chain packaging systems, such as insulated shippers and phase change materials, to ensure safe delivery worldwide. The continued growth of biologics pipelines is fueling investments in robust packaging solutions that can handle stringent thermal requirements.

With the globalization of the pharmaceutical industry, products are increasingly being manufactured in one region and distributed across multiple continents. This has intensified the need for reliable cold chain packaging solutions that can withstand long transit times, diverse climatic conditions, and multiple handling points. For example, Indian pharmaceutical manufacturers, who are among the largest exporters of generic drugs and vaccines, heavily depend on high-performance cold chain packaging to reach markets in North America, Europe, and Africa. As international trade volumes grow, particularly in emerging markets, demand for advanced cold chain packaging technologies such as vacuum-insulated panels, smart containers, and real-time monitoring systems is expected to surge.

Regulatory authorities such as the U.S. FDA, European Medicines Agency (EMA), and World Health Organization (WHO) mandate strict guidelines for the storage, handling, and transport of temperature-sensitive pharmaceuticals. Compliance with Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP) necessitates the adoption of validated cold chain packaging solutions that ensure consistent product integrity.

Advancements in cold chain packaging technologies, combined with growing emphasis on sustainability, are accelerating market expansion. Packaging solutions are becoming smarter, lighter, and eco-friendlier, offering extended thermal protection while reducing carbon footprint. Companies are adopting reusable insulated containers, recyclable phase change materials, and AI-enabled monitoring systems to enhance performance and efficiency. For example, Pelican BioThermal and Sonoco ThermoSafe offers reusable systems that not only meet strict temperature requirements but also align with the pharmaceutical industry's sustainability goals. These innovations not only help reduce costs over time but also appeal to regulators and consumers seeking greener supply chain practices.

Global Pharmaceutical Cold Chain Packaging Market Report Segmentation

This report forecasts revenue growth at a global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical cold chain packaging market report based on material, product, end use, and region:

• Material Outlook (Revenue, USD Million; Volume, Kilotons; 2021 - 2033)
• Plastic
  • Polyethylene (PE)
  • Polypropylene (PP)
  • Polyethylene Terephthalate (PET)
  • Expanded Polystyrene (EPS)
  • Polyurethane (PU)
  • Others
• Paper
• Metal
• Others
• Product Outlook (Revenue, USD Million; Volume, Kilotons; 2021 - 2033)
• Small Boxes
• Pallets
• Large Sized Pallet Containers
• Others
• End Use Outlook (Revenue, USD Million; Volume, Kilotons; 2021 - 2033)
• Biopharmaceutical Companies
• Clinical Research Organizations
• Hospitals
• Research Institutes
• Logistics and Distribution Companies
• Others
• Region Outlook (Revenue, USD Million; Volume, Kilotons; 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Research Methodology
  • 1.1.1. Market Segmentation
  • 1.1.2. Market Definition
• 1.2. Research Scope & Assumptions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing
• 1.7. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot, 2024 (USD Million)
• 2.2. Segmental Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Global Pharmaceutical Cold Chain Packaging Market Variables, Trends, and Scope

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Raw Material Trends
  • 3.3.2. Manufacturing/Technology Trends
  • 3.3.3. Sales Channel Analysis
  • 3.3.4. Profit Margin Analysis
• 3.4. Regulatory Framework
• 3.5. Market Dynamics
  • 3.5.1. Market Driver Analysis
  • 3.5.2. Market Restraint Analysis
  • 3.5.3. Market Opportunity Analysis
  • 3.5.4. Market Challenge Analysis
• 3.6. Business Environment Analysis
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL Analysis

Chapter 4. Global Pharmaceutical Cold Chain Packaging Market: Material Estimates & Trend Analysis

• 4.1. Key Takeaways
• 4.2. Material Movement Analysis & Market Share, 2024 & 2033
  • 4.2.1. Plastic
    • 4.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
    • 4.2.1.2. Polyethylene (PE)
      • 4.2.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
    • 4.2.1.3. Polypropylene (PP)
      • 4.2.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
    • 4.2.1.4. Polyethylene Terephthalate (PET)
      • 4.2.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
    • 4.2.1.5. Expanded Polystyrene (EPS)
      • 4.2.1.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
    • 4.2.1.6. Polyurethane (PU)
      • 4.2.1.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
    • 4.2.1.7. Others
      • 4.2.1.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 4.2.2. Paper
    • 4.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 4.2.3. Metal
    • 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 4.2.4. Others
    • 4.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)

Chapter 5. Global Pharmaceutical Cold Chain Packaging Market: Product Estimates & Trend Analysis

• 5.1. Key Takeaways
• 5.2. Product Movement Analysis & Market Share, 2024 & 2033
  • 5.2.1. Small Boxes
    • 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 5.2.2. Pallets
    • 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 5.2.3. Large Sized Pallet Containers
    • 5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 5.2.4. Others
    • 5.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)

Chapter 6. Global Pharmaceutical Cold Chain Packaging Market: End Use Estimates & Trend Analysis

• 6.1. Key Takeaways
• 6.2. End Use Movement Analysis & Market Share, 2024 & 2033
  • 6.2.1. Biopharmaceutical Companies
    • 6.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 6.2.2. Clinical Research Organizations
    • 6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 6.2.3. Hospitals
    • 6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 6.2.4. Research Institutes
    • 6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 6.2.5. Logistics and Distribution Companies
    • 6.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 6.2.6. Others
    • 6.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million) (Kilotons)

Chapter 7. Global Pharmaceutical Cold Chain Packaging Market: Region Estimates & Trend Analysis

• 7.1. Key Takeaways
• 7.2. Regional Movement Analysis & Market Share, 2024 & 2033
• 7.3. North America
  • 7.3.1. North America Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.3.2. U.S.
    • 7.3.2.1. U.S. Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.3.3. Canada
    • 7.3.3.1. Canada Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.3.4. Mexico
    • 7.3.4.1. Mexico Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
• 7.4. Europe
  • 7.4.1. Europe Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.4.2. Germany
    • 7.4.2.1. Germany Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.4.3. UK
    • 7.4.3.1. UK Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.4.4. France
    • 7.4.4.1. France Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.4.5. Italy
    • 7.4.5.1. Italy Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.4.6. Spain
    • 7.4.6.1. Spain Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.5.2. China
    • 7.5.2.1. China Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.5.3. India
    • 7.5.3.1. India Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.5.4. Japan
    • 7.5.4.1. Japan Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.5.5. South Korea
    • 7.5.5.1. South Korea Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.5.6. Australia
    • 7.5.6.1. Australia Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
• 7.6. Latin America
  • 7.6.1. Latin America Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.6.2. Brazil
    • 7.6.2.1. Brazil Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.6.3. Argentina
    • 7.6.3.1. Argentina Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Saudi Arabia Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.7.3. UAE
    • 7.7.3.1. UAE Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)
  • 7.7.4. South Africa
    • 7.7.4.1. South Africa Pharmaceutical Cold Chain Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million) (Kilotons)

Chapter 8. Competitive Landscape

• 8.1. Key Global Players & Recent Developments & Their Impact on the Industry
• 8.2. Company Categorization
• 8.3. Company Market Position Analysis
• 8.4. Company Heat Map Analysis
• 8.5. List of Potential Customers/End Users
• 8.6. Strategy Mapping
  • 8.6.1. Expansions
  • 8.6.2. Mergers & Acquisitions
  • 8.6.3. Collaborations
  • 8.6.4. New Product Launches
  • 8.6.5. Others

Chapter 9. Company Listing (Overview, Financial Performance, Product Overview)

• 9.1. Sonoco Thermosafe
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
• 9.2. Sealed Air
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
• 9.3. Peli BioThermal Limited
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
• 9.4. CSafe
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
• 9.5. Intelsius
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
• 9.6. Cryoport Systems, LLC
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
• 9.7. Envirotainer
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
• 9.8. SkyCell AG
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
• 9.9. va-Q-tec AG
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
• 9.10. Inmark Global Holdings, LLC
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
• 9.11. Smurfit Westrock
  • 9.11.1. Company Overview
  • 9.11.2. Financial Performance
  • 9.11.3. Product Benchmarking
• 9.12. Insulated Products Corporation
  • 9.12.1. Company Overview
  • 9.12.2. Financial Performance
  • 9.12.3. Product Benchmarking
• 9.13. Chill-Pak
  • 9.13.1. Company Overview
  • 9.13.2. Financial Performance
  • 9.13.3. Product Benchmarking
• 9.14. Practical Packaging Solutions, Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Financial Performance
  • 9.14.3. Product Benchmarking
• 9.15. TESSOL
  • 9.15.1. Company Overview
  • 9.15.2. Financial Performance
  • 9.15.3. Product Benchmarking
• 9.16. The Wool Packaging Company Limited
  • 9.16.1. Company Overview
  • 9.16.2. Financial Performance
  • 9.16.3. Product Benchmarking
• 9.17. Thermal Packaging Solutions Ltd.
  • 9.17.1. Company Overview
  • 9.17.2. Financial Performance
  • 9.17.3. Product Benchmarking
• 9.18. Hanchett Paper Company
  • 9.18.1. Company Overview
  • 9.18.2. Financial Performance
  • 9.18.3. Product Benchmarking
• 9.19. Topa Thermal
  • 9.19.1. Company Overview
  • 9.19.2. Financial Performance
  • 9.19.3. Product Benchmarking
• 9.20. Sofrigam
  • 9.20.1. Company Overview
  • 9.20.2. Financial Performance
  • 9.20.3. Product Benchmarking